Ingelheim, 16 November 2015 – Boehringer Ingelheim has been named one of the most innovative companies worldwide in 2015.
For the first time, the research-driven pharmaceutical company ranked among the 100 leading global innovators named by news agency Thomson Reuters.
Thomson Reuters has granted this award since 2011. To measure innovative strength and determine the winners, the news agency pursued a detailed scientific approach based on four principle criteria:
overall patent volume, patent application-to-grant success rate, global reach of the portfolio, and patent influence as evidenced by citations.
For further information go to http://www.stateofinnovation.com.
